<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxicol Rep</journal-id><journal-id journal-id-type="iso-abbrev">Toxicol Rep</journal-id><journal-id journal-id-type="pmc-domain-id">3294</journal-id><journal-id journal-id-type="pmc-domain">toxreps</journal-id><journal-title-group><journal-title>Toxicology Reports</journal-title></journal-title-group><issn pub-type="epub">2214-7500</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10165401</article-id><article-id pub-id-type="pmcid-ver">PMC10165401.1</article-id><article-id pub-id-type="pmcaid">10165401</article-id><article-id pub-id-type="pmcaiid">10165401</article-id><article-id pub-id-type="pmid">37168078</article-id><article-id pub-id-type="doi">10.1016/j.toxrep.2023.04.011</article-id><article-id pub-id-type="pii">S2214-7500(23)00048-3</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name name-style="western"><surname>Theerasuwipakorn</surname><given-names initials="N">Nonthikorn</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="fn1" ref-type="fn">1</xref><xref rid="fn2" ref-type="fn">2</xref></contrib><contrib contrib-type="author" id="au0010"><name name-style="western"><surname>Prechawat</surname><given-names initials="S">Somchai</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="fn1" ref-type="fn">1</xref><xref rid="fn3" ref-type="fn">3</xref></contrib><contrib contrib-type="author" id="au0015"><name name-style="western"><surname>Chokesuwattanaskul</surname><given-names initials="R">Ronpichai</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref><xref rid="fn4" ref-type="fn">4</xref></contrib><contrib contrib-type="author" id="au0020"><name name-style="western"><surname>Siranart</surname><given-names initials="N">Noppachai</given-names></name><xref rid="aff0015" ref-type="aff">c</xref><xref rid="fn5" ref-type="fn">5</xref></contrib><contrib contrib-type="author" id="au0025"><name name-style="western"><surname>Marsukjai</surname><given-names initials="A">Apichai</given-names></name><xref rid="aff0005" ref-type="aff">a</xref><xref rid="fn6" ref-type="fn">6</xref></contrib><contrib contrib-type="author" id="au0030"><name name-style="western"><surname>Thumtecho</surname><given-names initials="S">Suthimon</given-names></name><xref rid="aff0020" ref-type="aff">d</xref><xref rid="fn7" ref-type="fn">7</xref></contrib><contrib contrib-type="author" id="au0035"><name name-style="western"><surname>Rungpradubvong</surname><given-names initials="V">Voravut</given-names></name><email>voravut.r@chula.ac.th</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="aff0010" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">&#8270;</xref><xref rid="fn8" ref-type="fn">8</xref></contrib><aff id="aff0005"><label>a</label>Division of Cardiovascular Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Cardiac Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand</aff><aff id="aff0010"><label>b</label>Center of Excellence in Arrhythmia Research Chulalongkorn University, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand</aff><aff id="aff0015"><label>c</label>Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand</aff><aff id="aff0020"><label>d</label>Division of Toxicology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8270;</label>Correspondence to: King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand. <email>voravut.r@chula.ac.th</email></corresp><fn id="fn1"><label>1</label><p id="ntp0005">These authors contributed equally to this work</p></fn><fn id="fn2"><label>2</label><p id="ntp0010">ORCID 0000-0002-3521-7715</p></fn><fn id="fn3"><label>3</label><p id="ntp0015">ORCID 0000-0002-3872-4579</p></fn><fn id="fn4"><label>4</label><p id="ntp0020">ORCID 0000-0002-4463-7447</p></fn><fn id="fn5"><label>5</label><p id="ntp0025">ORCID 0000-0003-3315-6020</p></fn><fn id="fn6"><label>6</label><p id="ntp0030">ORCID 0000-0002-7330-879X</p></fn><fn id="fn7"><label>7</label><p id="ntp0035">ORCID 0000-0002-8853-6568</p></fn><fn id="fn8"><label>8</label><p id="ntp0040">ORCID 0000-0002-3661-1490</p></fn></author-notes><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>4</month><year>2023</year></pub-date><volume>10</volume><issue-id pub-id-type="pmc-issue-id">423082</issue-id><fpage>537</fpage><lpage>543</lpage><history><date date-type="received"><day>15</day><month>1</month><year>2023</year></date><date date-type="rev-recd"><day>5</day><month>4</month><year>2023</year></date><date date-type="accepted"><day>24</day><month>4</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>25</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>09</day><month>05</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-05-12 17:25:13.940"><day>12</day><month>05</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Authors. Published by Elsevier B.V.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder/><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="ab0010"><sec><title>Background</title><p>Cannabis is the most used illicit drug in the world. Global trends of decriminalization and legalization of cannabis lead to various forms of cannabis use and bring great concerns over adverse events, particularly in the cardiovascular (CV) system. To date, the association between cannabis and adverse CV events is still controversial.</p></sec><sec><title>Purpose</title><p>We aim to conduct a systematic review and meta-analysis to assess the adverse CV events from cannabis use.</p></sec><sec><title>Patients and methods</title><p>A systematic search for publications describing the adverse CV events of cannabis use, including acute myocardial infarction (MI) and stroke, was performed via PubMed, Scopus, and Cochrane Library databases. Data on effect estimates in individual studies were extracted and combined via random-effects meta-analysis using the DerSimonian and Laird method, a generic inverse-variance strategy.</p></sec><sec><title>Results</title><p>Twenty studies with a total of 183,410,651 patients were included. The proportion of males was 23.7%. The median age and follow-up time were 42.4 years old (IQR: 37.4, 50.0) and 6.2 years (IQR: 1.7, 27.7), respectively. The prevalence of cannabis use was 1.9%. Cannabis use was not significantly associated with acute MI (pooled odds ratio (OR): 1.29; 95%CI: 0.80, 2.08), stroke (pooled OR 1.35; 95%CI: 0.74, 2.47), and adverse CV events (pooled OR: 1.47; 95%CI: 0.98, 2.20).</p></sec><sec><title>Conclusion</title><p>The risk of adverse CV events including acute MI and stroke does not exhibit a significant increase with cannabis exposure. However, caution should be exercised when interpreting the findings due to the heterogeneity of the studies.</p></sec></abstract><abstract abstract-type="graphical" id="ab0015"><title>Graphical Abstract</title><p><fig id="fig0025" position="anchor" orientation="portrait"><alt-text id="at0030">ga1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="ga1.jpg"/></fig></p></abstract><abstract abstract-type="author-highlights" id="ab0020"><title>Highlights</title><p><list list-type="simple" id="li0005"><list-item id="u0005"><label>&#8226;</label><p id="p0005">Cannabis has been increasingly decriminalized or legalized for medical and recreational purposes in recent decades.</p></list-item><list-item id="u0010"><label>&#8226;</label><p id="p0010">The association between cannabis and adverse CV events is still controversial.</p></list-item><list-item id="u0015"><label>&#8226;</label><p id="p0015">This meta-analysis found that cannabis use was not significantly associated with acute MI, stroke, and adverse CV events.</p></list-item><list-item id="u0020"><label>&#8226;</label><p id="p0020">The plausible explanation for the inconsistent association is attributed to how cannabis is consumed in each study.</p></list-item><list-item id="u0025"><label>&#8226;</label><p id="p0025">Specific conditions of cannabis use e.g., preparation, route, dosage, duration, and time after exposure can affect outcomes and need further investigations.</p></list-item></list></p></abstract><kwd-group id="keys0005"><title>Keywords</title><kwd>Cannabis</kwd><kwd>Marijuana</kwd><kwd>Myocardial infarction</kwd><kwd>Stroke</kwd><kwd>Cardiovascular event</kwd><kwd>Systematic review</kwd><kwd>Meta-analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta><notes><p id="mis0005">Handling Editor: Dr. L.H. Lash</p></notes></front><body><sec id="sec0005"><label>1</label><title>Introduction</title><p id="p0035">Cannabis, also known as marijuana, is a plant-based preparation of <italic toggle="yes">Cannabis sativa</italic> and <italic toggle="yes">Cannabis indica</italic>. Cannabis use and cultivation were illegal and prohibited globally for its negative psychoactive properties in the past century <xref rid="bib1" ref-type="bibr">[1]</xref>, <xref rid="bib2" ref-type="bibr">[2]</xref>. However, given the millennium history of cannabis use and scientifically proven benefits, <xref rid="bib3" ref-type="bibr">[3]</xref> cannabis has been increasingly decriminalized or legalized for medical and recreational purposes in many countries in recent decades <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>, <xref rid="bib5" ref-type="bibr">[5]</xref>. Because of the lessened regulation, cannabis consumption has reached over 140 million people around the world <xref rid="bib6" ref-type="bibr">[6]</xref>.</p><p id="p0040">Cannabis contains hundreds of chemical compounds, including the well-known and extensively studied tetrahydrocannabinol (THC) and cannabidiol (CBD). These chemicals can modulate the human endocannabinoid system and produce distinct neurological and cardiovascular responses <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>. Because THC is believed to be associated with cannabinoid receptor type 1 (CB<sub>1</sub>R) mediated endothelial and autonomic dysfunction, concerns of acute and chronic effects, particularly cardiovascular (CV) adverse events ie, myocardial infarction (MI) and stroke, intensify as cannabis becomes less restricted <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib8" ref-type="bibr">[8]</xref>.</p><p id="p0045">Although published case reports and case series found links between adverse CV events and heavy cannabis use, <xref rid="bib9" ref-type="bibr">[9]</xref> data from the large national databases and many cohorts are still controversial <xref rid="bib5" ref-type="bibr">[5]</xref>. One of the largest United States databases showed that the frequency of MI and stroke were significantly higher in young cannabis users, <xref rid="bib10" ref-type="bibr">[10]</xref> while the data from UK Biobank suggested that cannabis might reduce the risk of MI. <xref rid="bib11" ref-type="bibr">[11]</xref> Many confounding factors may explain the conflicting data; for example, (i) the THC and CBD contents of the cannabis plant are various depending on each cultivation method, <xref rid="bib12" ref-type="bibr">[12]</xref>, <xref rid="bib13" ref-type="bibr">[13]</xref> (ii) the route of administration, dosage, duration, product preparation affect THC doses, and (iii) contamination of adulterants may contribute to significant CV side effects <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib14" ref-type="bibr">[14]</xref>.</p><p id="p0050">Considering the limitation to perform a randomized controlled trial due to ethical issues and data discrepancy, we aim to conduct a systematic review and the first meta-analysis to assess the adverse CV events from cannabis use.</p></sec><sec id="sec0010"><label>2</label><title>Material and methods</title><sec id="sec0015"><label>2.1</label><title>Search strategy</title><p id="p0055">We performed a systematic search from MEDLINE (PubMed), EMBASE (Scopus), and the Cochrane library databases from inception until July 2022 for publications that studied the adverse CV events of cannabis use. Two authors (N.T. and N.S.) independently gathered the systematic literature review using a search strategy that included the various terms representing 'cannabis' and 'adverse cardiovascular event' as stated in <xref rid="sec0100" ref-type="sec">supplementary data 1</xref>. Reference lists of recognized citations were manually searched for relevant studies as well. This systematic review and meta-analysis follow the Meta-analyses Of Observational Studies in Epidemiology (MOOSE) standards. In addition, it was conducted following the Preferred Reporting Items for Systematic Reviews, Meta-Analyses (PRISMA) statement. This review was not registered, however, the study protocol, data extraction forms, and data used for all analyses were located at King Chulalongkorn Memorial Hospital, Bangkok, Thailand.</p></sec><sec id="sec0020"><label>2.2</label><title>Study eligibility</title><p id="p0060">The inclusion criteria were cross-sectional, case-control, and prospective or retrospective cohort studies published in peer-review, English-language journals. The inclusion of studies was not restricted by sample size or population ethnicity. Cannabis use included all cannabis preparation, route of administration, dosage, and duration. Studies of FDA-approved cannabis drugs were excluded because these forms of cannabis have already been extensively examined under randomized controlled trials <xref rid="bib15" ref-type="bibr">[15]</xref>, <xref rid="bib16" ref-type="bibr">[16]</xref>, <xref rid="bib17" ref-type="bibr">[17]</xref>, <xref rid="bib18" ref-type="bibr">[18]</xref>, <xref rid="bib19" ref-type="bibr">[19]</xref>, <xref rid="bib20" ref-type="bibr">[20]</xref>. Editorials, reviews, conference abstracts, case reports, case series, systematic reviews, meta-analyses, and studies that the results could not be generated into a two-by-two table were also excluded. Any disagreements concerning study choices were settled through collaborative conversation.</p><p id="p0065">Two independent reviewers (N.S. and A.M.) reviewed abstracts and full texts. The third reviewer (N.T.) will make the final decision when the consensus could not be determined. A study with the largest number of patients was selected for the analysis when two or more studies had an overlapping population.</p></sec><sec id="sec0025"><label>2.3</label><title>Data extraction and outcomes</title><p id="p0070">The extracted data were first author, publication year, study site and country, study design, major inclusion, and exclusion criteria, age, gender, comorbidities, and follow-up time. The cannabis exposure data namely cannabis preparation, route of administration, dosage, and duration were collected. CV adverse events included in the meta-analysis were acute MI, stroke including hemorrhagic, ischemic stroke, and transient ischemic attack (TIA), and composite adverse CV events by definition of the individual study (when the definition was not provided, composite adverse CV events was comprised of acute MI and stroke).</p></sec><sec id="sec0030"><label>2.4</label><title>Pre-specified subgroups</title><p id="p0075">Pre-specified subgroup analyses were planned to stratify by preparation of cannabis, route of administration, dose, duration, and purpose of cannabis use if data were available.</p></sec><sec id="sec0035"><label>2.5</label><title>Quality assessment</title><p id="p0080">The Newcastle-Ottawa quality assessment (NOS) scale for cross-sectional and cohort studies was used to assess the quality of included studies, respectively. The assessment is based on eight domains categorized into three categories: patient selection, comparability, and exposure or outcome <xref rid="bib21" ref-type="bibr">[21]</xref>. Two reviewers (N.S. and A.M.) evaluated the study quality independently. Any disagreement was resolved by the consensus of the third reviewer (N.T.). Studies with a score of 6 or more were considered high-quality studies.</p></sec><sec id="sec0040"><label>2.6</label><title>Statistical analysis</title><p id="p0085">All statistical analyses were performed using R program version 4.2.0 (R Core Team, Vienna, Austria). A random-effects model was used to estimate the pooled odd ratios for all outcomes. DerSimonian and Laird's generic inverse variance technique was used to calculate adjusted point estimates from each study, which assigned a weight to each study based on its variance <xref rid="bib22" ref-type="bibr">[22]</xref>. Between-subgroup heterogeneity is tested by considering the dispersal of subgroup-specific pooled effects from the weighted average of subgroup effects under the specified model. The funnel plot and Egger test are used to determine whether there is publication bias <xref rid="bib23" ref-type="bibr">[23]</xref>.</p></sec></sec><sec id="sec0045"><label>3</label><title>Results</title><p id="p0090">A total of 2896 citations were acquired from a systematic search. Of these, 2753 citations were excluded by title and abstract screening, leaving 143 citations for full-text review. One hundred and twenty-three citations were excluded due to an ineligible population, incomplete raw data, redundant population, inappropriate outcome, and improper study design. Finally, 20 studies, which consist of 4 prospective cohorts, 9 retrospective cohorts, and 7 cross-sectional studies, were included in a systematic review. The urine toxicology screening, self-reporting to the interviewer or questionnaire, and the International Classification of Diseases Ninth Revision, Clinical Modification (ICD-9-CM) coding were used to assess exposure to cannabis. [<xref rid="fig0005" ref-type="fig">Fig. 1</xref>].<fig id="fig0005" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flow diagram of the selection of articles.</p></caption><alt-text id="at0005">Fig. 1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><sec id="sec0050"><label>3.1</label><title>Characteristics of included studies</title><p id="p0095">Of the 20 included studies, a total of 183,410,651 patients were enrolled with the number of participants in each study ranging from 51 to 118,659,619 patients. <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib30" ref-type="bibr">[30]</xref>, <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref> The median age was 42.4 years old (IQR: 37.4, 50.0). The proportion of males was 23.7%. The median follow-up time was 6.2 years (IQR: 1.7, 27.7, range from 242 days to 38 years). The prevalence of cannabis use was 3,549,117 patients (1.9%). All varieties of cannabis preparation, route of administration, and dosage are counted as cannabis use in all studies. Moreover, the details of these varieties are not well summarized. [<xref rid="tbl0005" ref-type="table">Table 1</xref>].<table-wrap position="float" id="tbl0005" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of included studies.</p></caption><alt-text id="at0025">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Author</th><th align="center" colspan="1" rowspan="1">Year</th><th align="center" colspan="1" rowspan="1">Study Design</th><th align="center" colspan="1" rowspan="1">Exposure assessment</th><th align="center" colspan="1" rowspan="1">Population</th><th align="center" colspan="1" rowspan="1">N</th><th align="center" colspan="1" rowspan="1">Age<break/>(years)</th><th align="center" colspan="1" rowspan="1">Male<break/>(%)</th><th align="center" colspan="1" rowspan="1">Outcome</th><th align="center" colspan="1" rowspan="1">Follow-up<break/>(years)</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Auger <xref rid="bib24" ref-type="bibr">[24]</xref></td><td align="center" colspan="1" rowspan="1">2020</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">ICD code</td><td align="center" colspan="1" rowspan="1">Pregnant women</td><td align="center" colspan="1" rowspan="1">1,247,035</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">0</td><td align="center" colspan="1" rowspan="1">MI, stroke, composite CV</td><td align="center" colspan="1" rowspan="1">30</td></tr><tr><td colspan="1" rowspan="1">Barber <xref rid="bib25" ref-type="bibr">[25]</xref></td><td align="center" colspan="1" rowspan="1">2013</td><td align="center" colspan="1" rowspan="1">Case-control</td><td align="center" colspan="1" rowspan="1">Urine test</td><td align="center" colspan="1" rowspan="1">Hospitalized patients aged 18&#8211;55 years</td><td align="center" colspan="1" rowspan="1">320</td><td align="center" colspan="1" rowspan="1">44.8&#8201;&#177;&#8201;8.5</td><td align="center" colspan="1" rowspan="1">60.6</td><td align="center" colspan="1" rowspan="1">Stroke</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Chami <xref rid="bib26" ref-type="bibr">[26]</xref></td><td align="center" colspan="1" rowspan="1">2019</td><td align="center" colspan="1" rowspan="1">Letter to editor, Retrospective cohort</td><td align="center" colspan="1" rowspan="1">N/A</td><td align="center" colspan="1" rowspan="1">N/A</td><td align="center" colspan="1" rowspan="1">10,835,118</td><td align="center" colspan="1" rowspan="1">37.4&#8201;&#177;&#8201;15</td><td align="center" colspan="1" rowspan="1">59.2</td><td align="center" colspan="1" rowspan="1">MI</td><td align="center" colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Desai <xref rid="bib10" ref-type="bibr">[10]</xref></td><td align="center" colspan="1" rowspan="1">2019</td><td align="center" colspan="1" rowspan="1">Case-control</td><td align="center" colspan="1" rowspan="1">ICD code</td><td align="center" colspan="1" rowspan="1">Hospitalized patients aged 18&#8211;39 years</td><td align="center" colspan="1" rowspan="1">52,290,927</td><td align="center" colspan="1" rowspan="1">27.3&#8201;&#177;&#8201;5.9</td><td align="center" colspan="1" rowspan="1">16.7</td><td align="center" colspan="1" rowspan="1">MI, stroke</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Dutta <xref rid="bib27" ref-type="bibr">[27]</xref></td><td align="center" colspan="1" rowspan="1">2021</td><td align="center" colspan="1" rowspan="1">Case-control</td><td align="center" colspan="1" rowspan="1">Self-report</td><td align="center" colspan="1" rowspan="1">Patients with first ischemic stroke aged 15&#8211;49 years</td><td align="center" colspan="1" rowspan="1">1,564</td><td align="center" colspan="1" rowspan="1">39.2</td><td align="center" colspan="1" rowspan="1">44.4</td><td align="center" colspan="1" rowspan="1">Stroke</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Falkstedt <xref rid="bib28" ref-type="bibr">[28]</xref></td><td align="center" colspan="1" rowspan="1">2017</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">Self-report</td><td align="center" colspan="1" rowspan="1">Young adults aged 18&#8211;20 years conscripted to military service</td><td align="center" colspan="1" rowspan="1">45,081</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">100</td><td align="center" colspan="1" rowspan="1">Stroke</td><td align="center" colspan="1" rowspan="1">38</td></tr><tr><td colspan="1" rowspan="1">Hemachandra <xref rid="bib29" ref-type="bibr">[29]</xref></td><td align="center" colspan="1" rowspan="1">2016</td><td align="center" colspan="1" rowspan="1">Cross-sectional</td><td align="center" colspan="1" rowspan="1">Self-report</td><td align="center" colspan="1" rowspan="1">Adults aged 20&#8211;64 years</td><td align="center" colspan="1" rowspan="1">7,455</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">49.1</td><td align="center" colspan="1" rowspan="1">Stroke</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Karki <xref rid="bib30" ref-type="bibr">[30]</xref></td><td align="center" colspan="1" rowspan="1">2022</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">Urine test</td><td align="center" colspan="1" rowspan="1">Hospitalized patients aged 18&#8211;54 years</td><td align="center" colspan="1" rowspan="1">14,490</td><td align="center" colspan="1" rowspan="1">46.3&#8201;&#177;&#8201;6.6</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">MI</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Ladha <xref rid="bib31" ref-type="bibr">[31]</xref></td><td align="center" colspan="1" rowspan="1">2021</td><td align="center" colspan="1" rowspan="1">Case-control</td><td align="center" colspan="1" rowspan="1">Self-report</td><td align="center" colspan="1" rowspan="1">Adults aged 18&#8211;44 years</td><td align="center" colspan="1" rowspan="1">33,173</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">50.5</td><td align="center" colspan="1" rowspan="1">MI</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Lehrer <xref rid="bib11" ref-type="bibr">[11]</xref></td><td align="center" colspan="1" rowspan="1">2022</td><td align="center" colspan="1" rowspan="1">Case-control</td><td align="center" colspan="1" rowspan="1">N/A</td><td align="center" colspan="1" rowspan="1">Adults</td><td align="center" colspan="1" rowspan="1">157,111</td><td align="center" colspan="1" rowspan="1">58</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">MI</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Lorenz <xref rid="bib32" ref-type="bibr">[32]</xref></td><td align="center" colspan="1" rowspan="1">2017</td><td align="center" colspan="1" rowspan="1">Prospective cohort</td><td align="center" colspan="1" rowspan="1">Self-report</td><td align="center" colspan="1" rowspan="1">HIV infected patients</td><td align="center" colspan="1" rowspan="1">414</td><td align="center" colspan="1" rowspan="1">41</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">Composite CV</td><td align="center" colspan="1" rowspan="1">6.59</td></tr><tr><td colspan="1" rowspan="1">Malhotra <xref rid="bib33" ref-type="bibr">[33]</xref></td><td align="center" colspan="1" rowspan="1">2018</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">ICD code</td><td align="center" colspan="1" rowspan="1">Hospitalized patients aged 15&#8211;54 years</td><td align="center" colspan="1" rowspan="1">118,659,619</td><td align="center" colspan="1" rowspan="1">50</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">Stroke</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Phillips <xref rid="bib34" ref-type="bibr">[34]</xref></td><td align="center" colspan="1" rowspan="1">2022</td><td align="center" colspan="1" rowspan="1">Prospective cohort</td><td align="center" colspan="1" rowspan="1">ICD code</td><td align="center" colspan="1" rowspan="1">Adults aged &#8805;&#8201;50 years</td><td align="center" colspan="1" rowspan="1">550</td><td align="center" colspan="1" rowspan="1">62.8&#8201;&#177;&#8201;7.3</td><td align="center" colspan="1" rowspan="1">69.5</td><td align="center" colspan="1" rowspan="1">MI, stroke</td><td align="center" colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Reis <xref rid="bib35" ref-type="bibr">[35]</xref></td><td align="center" colspan="1" rowspan="1">2017</td><td align="center" colspan="1" rowspan="1">Prospective cohort</td><td align="center" colspan="1" rowspan="1">Self-report</td><td align="center" colspan="1" rowspan="1">Young adults aged 18&#8211;30 years</td><td align="center" colspan="1" rowspan="1">5,113</td><td align="center" colspan="1" rowspan="1">25</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">MI, stroke, composite CV</td><td align="center" colspan="1" rowspan="1">26.9</td></tr><tr><td colspan="1" rowspan="1">San <xref rid="bib36" ref-type="bibr">[36]</xref></td><td align="center" colspan="1" rowspan="1">2020</td><td align="center" colspan="1" rowspan="1">Cross-sectional</td><td align="center" colspan="1" rowspan="1">Urine test</td><td align="center" colspan="1" rowspan="1">Patients with urine drug screening on admission</td><td align="center" colspan="1" rowspan="1">9,350</td><td align="center" colspan="1" rowspan="1">44</td><td align="center" colspan="1" rowspan="1">53.9</td><td align="center" colspan="1" rowspan="1">Stroke</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Sarmiento <xref rid="bib37" ref-type="bibr">[37]</xref></td><td align="center" colspan="1" rowspan="1">2021</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">Urine test</td><td align="center" colspan="1" rowspan="1">Type A aortic dissection</td><td align="center" colspan="1" rowspan="1">51</td><td align="center" colspan="1" rowspan="1">54.7</td><td align="center" colspan="1" rowspan="1">74.5</td><td align="center" colspan="1" rowspan="1">Stroke</td><td align="center" colspan="1" rowspan="1">0.08</td></tr><tr><td colspan="1" rowspan="1">Stupinski <xref rid="bib38" ref-type="bibr">[38]</xref></td><td align="center" colspan="1" rowspan="1">2020</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">ICD code</td><td align="center" colspan="1" rowspan="1">Traumatic patients</td><td align="center" colspan="1" rowspan="1">678</td><td align="center" colspan="1" rowspan="1">34&#8201;&#177;&#8201;15</td><td align="center" colspan="1" rowspan="1">83.0</td><td align="center" colspan="1" rowspan="1">MI, stroke</td><td align="center" colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Sun <xref rid="bib39" ref-type="bibr">[39]</xref></td><td align="center" colspan="1" rowspan="1">2020</td><td align="center" colspan="1" rowspan="1">Prospective cohort</td><td align="center" colspan="1" rowspan="1">Self-report</td><td align="center" colspan="1" rowspan="1">Adults</td><td align="center" colspan="1" rowspan="1">14,818</td><td align="center" colspan="1" rowspan="1">38.2&#8201;&#177;&#8201;11.3</td><td align="center" colspan="1" rowspan="1">50.7</td><td align="center" colspan="1" rowspan="1">Composite CV</td><td align="center" colspan="1" rowspan="1">5.8</td></tr><tr><td colspan="1" rowspan="1">Winhusen <xref rid="bib40" ref-type="bibr">[40]</xref></td><td align="center" colspan="1" rowspan="1">2020</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">ICD code, urine test</td><td align="center" colspan="1" rowspan="1">Adults aged &#8805;&#8201;18 years</td><td align="center" colspan="1" rowspan="1">17,888</td><td align="center" colspan="1" rowspan="1">42.4&#8201;&#177;&#8201;13.6</td><td align="center" colspan="1" rowspan="1">56.8</td><td align="center" colspan="1" rowspan="1">MI, stroke</td><td align="center" colspan="1" rowspan="1">7.5</td></tr><tr><td colspan="1" rowspan="1">Zongo <xref rid="bib41" ref-type="bibr">[41]</xref></td><td align="center" colspan="1" rowspan="1">2021</td><td align="center" colspan="1" rowspan="1">Retrospective cohort</td><td align="center" colspan="1" rowspan="1">N/A</td><td align="center" colspan="1" rowspan="1">Adults with cannabis authorization for medical uses</td><td align="center" colspan="1" rowspan="1">69,896</td><td align="center" colspan="1" rowspan="1">-</td><td align="center" colspan="1" rowspan="1">54.6</td><td align="center" colspan="1" rowspan="1">Composite CV (MI and stroke)</td><td align="center" colspan="1" rowspan="1">0.66</td></tr></tbody></table><table-wrap-foot><fn id="sp0030"><p>CV =&#8201;cardiovascular; ICD =&#8201;International Classification of Diseases; MI =&#8201;myocardial infarction; N/A =&#8201;not applicable</p></fn><fn id="sp0035"><p>Notes:</p></fn><fn id="sp0040"><p><bold>Abbreviations:</bold> CV =&#8201;cardiovascular; ICD =&#8201;International Classification of Diseases; MI =&#8201;myocardial infarction; N/A =&#8201;not applicable</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec0055"><label>3.2</label><title>Cannabis use and acute myocardial infarction</title><p id="p0100">Ten studies with a total of 64,602,083 patients reported acute MI, which occurred in 144,716 patients (0.22%) <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib30" ref-type="bibr">[30]</xref>, <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>. The pooled OR and rates of acute MI were shown in [<xref rid="fig0010" ref-type="fig">Fig. 2</xref>]. Cannabis use predicted acute MI with a pooled OR of 1.29 (95%CI: 0.80, 2.08). The heterogeneity I<sup>2</sup> and <italic toggle="yes">&#964;</italic> were 99% and 0.30 (p&#8201;&lt;&#8201;0.01), respectively.<fig id="fig0010" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Forest plot of analysis regarding myocardial infarction. Individual trials and pooled analyses revealed an insignificant increase risk of acute MI in the cannabis use group. CI =&#8201;confidence interval; MI =&#8201;myocardial infarction; OR =&#8201;odds ratio.</p></caption><alt-text id="at0010">Fig. 2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p></sec><sec id="sec0060"><label>3.3</label><title>Cannabis use and stroke</title><p id="p0105">Thirteen studies with a total of 172,285,631 patients reported stroke, which occurred in 248,563 patients (0.14%) <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>. The pooled OR and rates of stroke were shown in [<xref rid="fig0015" ref-type="fig">Fig. 3</xref>]. Cannabis use predicted stroke with a pooled OR of 1.35 (95%CI: 0.74, 2.47). The heterogeneity I<sup>2</sup> and <italic toggle="yes">&#964;</italic> were 97% and 0.74 (p&#8201;&lt;&#8201;0.01), respectively.<fig id="fig0015" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Forest plot of analysis regarding stroke. Individual trials and pooled analyses revealed an insignificant increase risk of stroke in the cannabis use group. CI =&#8201;confidence interval; OR =&#8201;odds ratio.</p></caption><alt-text id="at0015">Fig. 3</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig></p><p id="p0110">Regarding the separate analyses of ischemic stroke including TIA and hemorrhagic stroke, the pooled OR were 1.52 (95%CI: 0.66, 3.51) and 2.03 (95%CI: 0.65, 6.34), respectively. The population heterogeneities in both analyses were shown in <xref rid="sec0100" ref-type="sec">Supplementary figures 1 and 2</xref>.</p></sec><sec id="sec0065"><label>3.4</label><title>Cannabis use and composite adverse cardiovascular event</title><p id="p0115">Twenty studies with a total of 183,410,651 patients reported composite adverse CV events, which occurred in 313,703 patients (0.17%) <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib30" ref-type="bibr">[30]</xref>, <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>. The pooled OR and rates of composite adverse CV events were shown in [<xref rid="fig0020" ref-type="fig">Fig. 4</xref>]. Cannabis use predicted composite adverse CV events with a pooled OR of 1.47 (95%CI: 0.98, 2.20). The heterogeneity I<sup>2</sup> and <italic toggle="yes">&#964;</italic> were 99% and 0.61 (p&#8201;&lt;&#8201;0.01), respectively.<fig id="fig0020" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Forest plot of analysis regarding composite adverse cardiovascular events. Individual trials and pooled analyses revealed an insignificant increase risk of composite adverse CV events in the cannabis use group. CI =&#8201;confidence interval; CV =&#8201;cardiovascular; OR =&#8201;odds ratio.</p></caption><alt-text id="at0020">Fig. 4</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr4.jpg"/></fig></p><p id="p0120">Four studies provided their own definition for composite cardiovascular events [<xref rid="sec0100" ref-type="sec">Supplementary data 2]</xref>
<xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>. The summation of acute MI and stroke was used as a composite cardiovascular event in the remaining studies. Since there were different definitions among studies, the sensitivity analysis was performed by analyzing only sixteen studies with similar definitions of a composite cardiovascular event. The sensitivity analysis result was not different from the main analysis [<xref rid="sec0100" ref-type="sec">Supplementary figure 3]</xref>.</p></sec><sec id="sec0070"><label>3.5</label><title>Quality assessment and risk of publication bias</title><p id="p0125">All included studies had a NOS score of 6 or more and were considered high-quality studies. [<xref rid="sec0100" ref-type="sec">Supplementary tables 1 and 2]</xref>. The funnel plots of acute MI and stroke appeared symmetrical consistent with the Egger test results (p-value = 0.188 and 0.058, respectively). However, the funnel plot and Egger test for composite adverse CV events showed evidence of publication bias (p-value = 0.005) [Supplementary figures 4&#8211;8].</p></sec></sec><sec id="sec0075"><label>4</label><title>Discussion</title><p id="p0130">Contrary to the notions based on previous literature and biological explanations, this meta-analysis found that cannabis use insignificantly predicts all major cardiovascular adverse events. During the median follow-up time of 6.2 years, the pooled ORs were 1.29 (95%CI: 0.80, 2.08) for acute MI, 1.35 (95%CI: 0.74, 2.47) for stroke, and 1.47 (95%CI: 0.98, 2.20) for composite adverse CV events. This study gathers 20 studies with over 183,000,000 patients, including 4 prospective cohorts, 9 retrospective cohorts, and 7 cross-sectional studies. The prevalence of cannabis use was 3,549,117 patients (1.9%), ranging from 0.3% to 83.8%. Most studies did not clearly demonstrate cannabis preparation, route of administration, dosage, duration, and purpose of use (medical or recreational) in their study participants, which may influence the study results.</p><p id="p0135">To the best of our knowledge, the current study is the first meta-analysis regarding cannabis-related adverse cardiovascular events, including acute MI and stroke, though, there are some systematic reviews on this topic. From the latest systematic review <xref rid="bib42" ref-type="bibr">[42]</xref>, 3 studies demonstrated the association between cannabis use and myocardial infarction <xref rid="bib43" ref-type="bibr">[43]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib45" ref-type="bibr">[45]</xref>. One of 3 studies found that the risk of MI increased 4.8 times within the first hour after cannabis exposure and 1.7 times in the second hour, emphasizing the significant relation between time after cannabis exposure and risk of MI. <xref rid="bib45" ref-type="bibr">[45]</xref> Supported by the previous systematic review of case series and case reports, the average onset of MI was within 5&#8201;h after the last cannabis exposure. <xref rid="bib9" ref-type="bibr">[9]</xref> Platelet activation, aggregation, and vasospasm play a central role in the pathogenesis of myocardial infarction and ischemic stroke. THC has been found to be a prothrombotic substance by inducing platelet aggregation. Although the mechanism of this effect is unclear, in vitro study demonstrated that CB<sub>1</sub>R and CB<sub>2</sub>R are both present on platelet membranes. During the activation of CB<sub>1</sub>R, moreover, fibrinogen receptors, glycoprotein IIb-IIIa and P-selectin&#160;expression on platelet membranes also increase in a dose-dependent fashion which may initiate a coagulation cascade. <xref rid="bib46" ref-type="bibr">[46]</xref> THC may also induce endothelial irritation and autonomic nervous system dysfunction resulting in vasospasm <xref rid="bib8" ref-type="bibr">[8]</xref>, <xref rid="bib47" ref-type="bibr">[47]</xref>. However, long-term exposure to THC leads to the downregulation of CB<sub>1</sub>R and physiologic response to THC <xref rid="bib48" ref-type="bibr">[48]</xref>. This meta-analysis found a trend, but not statistically significant, toward MI in the cannabis-using group. The insignificant result might be influenced by the higher proportion of patients who reported chronic cannabis use in the included studies than in the published case reports and case series.</p><p id="p0140">Seven of 9 studies from the previous review <xref rid="bib42" ref-type="bibr">[42]</xref> showed the association between cannabis use and stroke (3 with ischemic stroke, 1 with hemorrhagic, and 3 with all stroke forms) <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib44" ref-type="bibr">[44]</xref>, <xref rid="bib49" ref-type="bibr">[49]</xref>, <xref rid="bib50" ref-type="bibr">[50]</xref>, <xref rid="bib51" ref-type="bibr">[51]</xref>, <xref rid="bib52" ref-type="bibr">[52]</xref>, <xref rid="bib53" ref-type="bibr">[53]</xref>, while 2 studies (1 with ischemic stroke and 1 with all stroke forms) were not <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>. However, it is noteworthy that the participants in 5 of 7 positive studies were the United States population and 4 studies used data from the national registry, the nationwide inpatient sample, which can result in overlapping enrollment <xref rid="bib49" ref-type="bibr">[49]</xref>, <xref rid="bib50" ref-type="bibr">[50]</xref>, <xref rid="bib51" ref-type="bibr">[51]</xref>, <xref rid="bib52" ref-type="bibr">[52]</xref>, <xref rid="bib53" ref-type="bibr">[53]</xref>. There was evidence that the frequency of cannabis use was related to the risk of stroke <xref rid="bib29" ref-type="bibr">[29]</xref>. Our result found that the stroke risk; including ischemic stroke, TIA, and hemorrhagic stroke, increased in the cannabis-using group, despite, insignificant results.</p><p id="p0145">This study has several limitations. First, although we performed an extensive systematic search via several large databases, the results are still subject to publication bias as demonstrated by asymmetrical funnel plots and the Egger test result of a composite adverse CV event. Second, there was population heterogeneity in the analysis for acute MI, stroke, and composite adverse CV events. Not only the inclusion and exclusion criteria in the individual studies are varied, but the diversity of cannabis use is also a great contributor to heterogeneity. Thus, we used the random-effect model in our meta-analysis for this reason. Third, most of the included studies are cross-sectional and retrospective studies which include participants from the pre-existing cohort, national registry, and survey <xref rid="bib10" ref-type="bibr">[10]</xref>, <xref rid="bib11" ref-type="bibr">[11]</xref>, <xref rid="bib24" ref-type="bibr">[24]</xref>, <xref rid="bib26" ref-type="bibr">[26]</xref>, <xref rid="bib27" ref-type="bibr">[27]</xref>, <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib30" ref-type="bibr">[30]</xref>, <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib33" ref-type="bibr">[33]</xref>, <xref rid="bib34" ref-type="bibr">[34]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib38" ref-type="bibr">[38]</xref>, <xref rid="bib39" ref-type="bibr">[39]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref>, <xref rid="bib41" ref-type="bibr">[41]</xref>. Hence, the data recorded in these studies were not pre-specified for cannabis use and could lead to information bias. Fourth, only five studies used urine toxicology tests to identify cannabis users <xref rid="bib25" ref-type="bibr">[25]</xref>, <xref rid="bib30" ref-type="bibr">[30]</xref>, <xref rid="bib36" ref-type="bibr">[36]</xref>, <xref rid="bib37" ref-type="bibr">[37]</xref>, <xref rid="bib40" ref-type="bibr">[40]</xref> while other studies collected data using participants&#8217; self-report in questionnaires or interviews, which could be the source of recall bias. Fifth, the analysis of arrhythmia, another commonly reported CV event <xref rid="bib54" ref-type="bibr">[54]</xref>, was not included due to a limited number of previous studies. <xref rid="bib55" ref-type="bibr">[55]</xref>, <xref rid="bib56" ref-type="bibr">[56]</xref> Exploring the association between cannabis and arrhythmia with an appropriate methodological approach is encouraged. Lastly, most studies included in this meta-analysis did not specifically describe how cannabis was used (e.g., preparation, route, dose, duration, and usage purpose). Five studies had reported the frequency of cannabis use. <xref rid="bib28" ref-type="bibr">[28]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>, <xref rid="bib31" ref-type="bibr">[31]</xref>, <xref rid="bib32" ref-type="bibr">[32]</xref>, <xref rid="bib35" ref-type="bibr">[35]</xref> However, given the small number of studies and different units of frequency reported, a subgroup analysis stratified by these factors cannot be performed even if it has already pre-specified.</p><p id="p0150">We believe the plausible explanation for the inconsistent association between cannabis exposure and adverse CV events is mainly attributed to how cannabis is consumed in each study because the route of administration, dosage (including THC percentage), duration, and time after exposure greatly affect adverse events <xref rid="bib5" ref-type="bibr">[5]</xref>, <xref rid="bib7" ref-type="bibr">[7]</xref>, <xref rid="bib9" ref-type="bibr">[9]</xref>, <xref rid="bib29" ref-type="bibr">[29]</xref>. Future research should focus on specific exposure conditions to cannabis that leads to serious outcomes.</p></sec><sec id="sec0080"><label>5</label><title>Conclusion</title><p id="p0155">The risk of adverse CV events, including acute MI and stroke, is not significantly increased with cannabis exposure. However, considering the heterogeneity among studies, it is vital to take a cautious stance toward the findings. Specific conditions of cannabis use such as cannabis preparation, route of administration, dosage, duration, and time after exposure can affect outcomes, and further investigations are needed.</p></sec><sec id="sec0085"><title>Funding</title><p id="p0160">None.</p></sec><sec id="sec0090"><title>CRediT authorship contribution statement</title><p id="p0165">Conception and design of study: N. Theerasuwipakorn, R. Chokesuwattanasakul, N. Siranart; acquisition of data: N. Theerasuwipakorn, A. Marsukjai; analysis and/or interpretation of data: N. Theerasuwipakorn, S. Prechawat, R. Chokesuwattanasakul, N. Siranart, A. Marsukjai, S. Thumtecho, V. Rungpradubvong. Drafting the manuscript: N. Theerasuwipakorn, A. Marsukjai; revising the manuscript critically for important intellectual content: N. Theerasuwipakorn, S. Prechawat, R. Chokesuwattanasakul, N. Siranart, A. Marsukjai, S. Thumtecho, V. Rungpradubvong. Approval of the version of the manuscript to be published (the names of all authors must be listed): N. Theerasuwipakorn, S. Prechawat, R. Chokesuwattanasakul, N. Siranart, A. Marsukjai, S. Thumtecho, V. Rungpradubvong.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="p0170">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ref-list id="bibliog0005"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sbref1"><person-group person-group-type="author"><name name-style="western"><surname>Adrian</surname><given-names>M.</given-names></name></person-group><article-title>What the history of drugs can teach us about the current cannabis legalization process: unfinished business</article-title><source>Subst. Use Misuse</source><volume>50</volume><issue>8&#8211;9</issue><year>2015</year><fpage>990</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">26361906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/10826084.2015.1013725</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sbref2"><person-group person-group-type="author"><name name-style="western"><surname>Haffajee</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>MacCoun</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Mello</surname><given-names>M.M.</given-names></name></person-group><article-title>Behind schedule - reconciling federal and state marijuana policy</article-title><source>N. Engl. J. Med</source><volume>379</volume><issue>6</issue><year>2018</year><fpage>501</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">29996065</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMp1804408</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref3"><person-group person-group-type="author"><name name-style="western"><surname>Zuardi</surname><given-names>A.W.</given-names></name></person-group><article-title>History of cannabis as a medicine: a review</article-title><source>Braz. J. Psychiatry</source><volume>28</volume><issue>2</issue><year>2006</year><fpage>153</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">16810401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/s1516-44462006000200015</pub-id></element-citation></ref><ref id="bib4"><label>4</label><mixed-citation publication-type="other" id="othref0005">DISA Global Solutions. Map of marijuana legality by state. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://disa.com/map-of-marijuana-legality-by-state" id="ir0010">&#9001;https://disa.com/map-of-marijuana-legality-by-state&#9002;</ext-link>. Accessed August 02, 2022.</mixed-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sbref4"><person-group person-group-type="author"><name name-style="western"><surname>Page</surname><given-names>R.L.</given-names><suffix>2nd</suffix></name><name name-style="western"><surname>Allen</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Carriker</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Martel</surname><given-names>C.</given-names></name><name name-style="western"><surname>Morris</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>Medical marijuana, recreational cannabis, and cardiovascular health: a scientific statement from the american heart association</article-title><source>Circulation</source><volume>142</volume><issue>10</issue><year>2020</year><fpage>e131</fpage><lpage>e152</lpage><pub-id pub-id-type="pmid">32752884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIR.0000000000000883</pub-id></element-citation></ref><ref id="bib6"><label>6</label><mixed-citation publication-type="other" id="othref0010">World Health Organization. Cannabis. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis" id="ir0015">&#9001;https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive/cannabis&#9002;</ext-link>. Accessed August 2, 2022.</mixed-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sbref5"><person-group person-group-type="author"><name name-style="western"><surname>Pacher</surname><given-names>P.</given-names></name><name name-style="western"><surname>Steffens</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hask&#243;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Schindler</surname><given-names>T.H.</given-names></name><name name-style="western"><surname>Kunos</surname><given-names>G.</given-names></name></person-group><article-title>Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly</article-title><source>Nat. Rev. Cardiol.</source><volume>15</volume><issue>3</issue><year>2018</year><fpage>151</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">28905873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrcardio.2017.130</pub-id></element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sbref6"><person-group person-group-type="author"><name name-style="western"><surname>Subramaniam</surname><given-names>V.N.</given-names></name><name name-style="western"><surname>Menezes</surname><given-names>A.R.</given-names></name><name name-style="western"><surname>DeSchutter</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lavie</surname><given-names>C.J.</given-names></name></person-group><article-title>The cardiovascular effects of marijuana: are the potential adverse effects worth the high?</article-title><source>Mo Med</source><volume>116</volume><issue>2</issue><year>2019</year><fpage>146</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">31040502</pub-id><pub-id pub-id-type="pmcid">PMC6461323</pub-id></element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sbref7"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Kamil</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Bachu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Adikey</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ravat</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Marijuana use and acute myocardial infarction: a systematic review of published cases in the literature</article-title><source>Trends Cardiovasc Med</source><volume>30</volume><issue>5</issue><year>2020</year><fpage>298</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">31439383</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tcm.2019.08.003</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sbref8"><person-group person-group-type="author"><name name-style="western"><surname>Desai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fong</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>V.P.</given-names></name><name name-style="western"><surname>Savani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gangani</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Rising trends in hospitalizations for cardiovascular events among young cannabis users (18-39 Years) without other substance abuse</article-title><source>Med. (Kaunas. )</source><volume>55</volume><issue>8</issue><year>2019</year><fpage>438</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medicina55080438</pub-id><pub-id pub-id-type="pmcid">PMC6723728</pub-id><pub-id pub-id-type="pmid">31387198</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sbref9"><person-group person-group-type="author"><name name-style="western"><surname>Lehrer</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rheinstein</surname><given-names>P.H.</given-names></name></person-group><article-title>Marijuana and myocardial infarction in the UK biobank cohort</article-title><source>Cureus</source><volume>14</volume><issue>2</issue><year>2022</year><object-id pub-id-type="publisher-id">e22054</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.22054</pub-id><pub-id pub-id-type="pmcid">PMC8826760</pub-id><pub-id pub-id-type="pmid">35165641</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sbref10"><person-group person-group-type="author"><name name-style="western"><surname>Magagnini</surname><given-names>G.</given-names></name><name name-style="western"><surname>Grassi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kotiranta</surname><given-names>S.</given-names></name></person-group><article-title>The effect of light spectrum on the morphology and cannabinoid content of cannabis sativa L</article-title><source>Med Cannabis Cannabinoids</source><volume>1</volume><issue>1</issue><year>2018</year><fpage>19</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">34676318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000489030</pub-id><pub-id pub-id-type="pmcid">PMC8489345</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sbref11"><person-group person-group-type="author"><name name-style="western"><surname>Stuyt</surname><given-names>E.</given-names></name></person-group><article-title>The problem with the current high potency THC marijuana from the perspective of an addiction psychiatrist</article-title><source>Mo Med</source><volume>115</volume><issue>6</issue><year>2018</year><fpage>482</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">30643324</pub-id><pub-id pub-id-type="pmcid">PMC6312155</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sbref12"><person-group person-group-type="author"><name name-style="western"><surname>Dabiri</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Kassab</surname><given-names>G.S.</given-names></name></person-group><article-title>Effects of cannabis on cardiovascular system: the good, the bad, and the many unknowns</article-title><source>Med. Cannabis Cannabinoids</source><volume>4</volume><issue>2</issue><year>2021</year><fpage>75</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">35224427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000519775</pub-id><pub-id pub-id-type="pmcid">PMC8832198</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sbref13"><person-group person-group-type="author"><name name-style="western"><surname>Andries</surname><given-names>A.</given-names></name><name name-style="western"><surname>Frystyk</surname><given-names>J.</given-names></name><name name-style="western"><surname>Flyvbjerg</surname><given-names>A.</given-names></name><name name-style="western"><surname>St&#248;ving</surname><given-names>R.K.</given-names></name></person-group><article-title>Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial</article-title><source>Int J. Eat. Disord.</source><volume>47</volume><issue>1</issue><year>2014</year><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">24105610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eat.22173</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sbref14"><person-group person-group-type="author"><name name-style="western"><surname>Bajtel</surname><given-names>&#193;.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>T.</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kiss</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hegyi</surname><given-names>P.</given-names></name><name name-style="western"><surname>V&#246;rhendi</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The safety of dronabinol and nabilone: a systematic review and meta-analysis of clinical trials</article-title><source>Pharmaceuticals</source><volume>15</volume><issue>1</issue><year>2022</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ph15010100</pub-id><pub-id pub-id-type="pmcid">PMC8778752</pub-id><pub-id pub-id-type="pmid">35056154</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sbref15"><person-group person-group-type="author"><name name-style="western"><surname>Devinsky</surname><given-names>O.</given-names></name><name name-style="western"><surname>Cross</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Laux</surname><given-names>L.</given-names></name><name name-style="western"><surname>Marsh</surname><given-names>E.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>I.</given-names></name><name name-style="western"><surname>Nabbout</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Trial of cannabidiol for drug-resistant seizures in the dravet syndrome</article-title><source>New Engl. J. Med</source><volume>376</volume><issue>21</issue><year>2017</year><fpage>2011</fpage><lpage>2020</lpage><pub-id pub-id-type="pmid">28538134</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1611618</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sbref16"><person-group person-group-type="author"><name name-style="western"><surname>Schimrigk</surname><given-names>S.</given-names></name><name name-style="western"><surname>Marziniak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Neubauer</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kugler</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Werner</surname><given-names>G.</given-names></name><name name-style="western"><surname>Abramov-Sommariva</surname><given-names>D.</given-names></name></person-group><article-title>Dronabinol is a safe long-term treatment option for neuropathic pain patients</article-title><source>Eur. Neurol.</source><volume>78</volume><issue>5&#8211;6</issue><year>2017</year><fpage>320</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">29073592</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000481089</pub-id><pub-id pub-id-type="pmcid">PMC5804828</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sbref17"><person-group person-group-type="author"><name name-style="western"><surname>Thiele</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Bebin</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Filloux</surname><given-names>F.</given-names></name><name name-style="western"><surname>Kwan</surname><given-names>P.</given-names></name><name name-style="western"><surname>Loftus</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial</article-title><source>Epilepsia</source><volume>63</volume><issue>2</issue><year>2022</year><fpage>426</fpage><lpage>439</lpage><pub-id pub-id-type="pmid">34957550</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/epi.17150</pub-id><pub-id pub-id-type="pmcid">PMC9305454</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sbref18"><person-group person-group-type="author"><name name-style="western"><surname>Thiele</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Bebin</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Bhathal</surname><given-names>H.</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>F.E.</given-names></name><name name-style="western"><surname>Kotulska</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lawson</surname><given-names>J.A.</given-names></name><etal/></person-group><article-title>Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial</article-title><source>JAMA Neurol.</source><volume>78</volume><issue>3</issue><year>2021</year><fpage>285</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">33346789</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2020.4607</pub-id><pub-id pub-id-type="pmcid">PMC7754080</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sbref19"><person-group person-group-type="author"><name name-style="western"><surname>Stang</surname><given-names>A.</given-names></name></person-group><article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title><source>Eur. J. Epidemiol.</source><volume>25</volume><issue>9</issue><year>2010</year><fpage>603</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">20652370</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10654-010-9491-z</pub-id></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sbref20"><person-group person-group-type="author"><name name-style="western"><surname>DerSimonian</surname><given-names>R.</given-names></name><name name-style="western"><surname>Laird</surname><given-names>N.</given-names></name></person-group><article-title>Meta-analysis in clinical trials</article-title><source>Control Clin. Trials</source><volume>7</volume><issue>3</issue><year>1986</year><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">3802833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0197-2456(86)90046-2</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sbref21"><person-group person-group-type="author"><name name-style="western"><surname>Easterbrook</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Berlin</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Gopalan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>D.R.</given-names></name></person-group><article-title>Publication bias in clinical research</article-title><source>Lancet</source><volume>337</volume><issue>8746</issue><year>1991</year><fpage>867</fpage><lpage>872</lpage><pub-id pub-id-type="pmid">1672966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0140-6736(91)90201-y</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sbref22"><person-group person-group-type="author"><name name-style="western"><surname>Auger</surname><given-names>N.</given-names></name><name name-style="western"><surname>Paradis</surname><given-names>G.</given-names></name><name name-style="western"><surname>Low</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ayoub</surname><given-names>A.</given-names></name><name name-style="western"><surname>He</surname><given-names>S.</given-names></name><name name-style="western"><surname>Potter</surname><given-names>B.J.</given-names></name></person-group><article-title>Cannabis use disorder and the future risk of cardiovascular disease in parous women: a longitudinal cohort study</article-title><source>BMC Med</source><volume>18</volume><issue>1</issue><year>2020</year><fpage>328</fpage><pub-id pub-id-type="pmid">33208143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12916-020-01804-6</pub-id><pub-id pub-id-type="pmcid">PMC7677785</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sbref23"><person-group person-group-type="author"><name name-style="western"><surname>Barber</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Pridmore</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Krishnamurthy</surname><given-names>V.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>S.</given-names></name><name name-style="western"><surname>Spriggs</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Carter</surname><given-names>K.N.</given-names></name><etal/></person-group><article-title>Cannabis, ischemic stroke, and transient ischemic attack: a case-control study</article-title><source>Stroke</source><volume>44</volume><issue>8</issue><year>2013</year><fpage>2327</fpage><lpage>2329</lpage><pub-id pub-id-type="pmid">23696547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.113.001562</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sbref24"><person-group person-group-type="author"><name name-style="western"><surname>Chami</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>C.H.</given-names></name></person-group><article-title>Cannabis abuse and elevated risk of myocardial infarction in the young: a population-based study</article-title><source>Mayo Clin. Proc.</source><volume>94</volume><issue>8</issue><year>2019</year><fpage>1647</fpage><lpage>1649</lpage><pub-id pub-id-type="pmid">31378243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mayocp.2019.05.008</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sbref25"><person-group person-group-type="author"><name name-style="western"><surname>Dutta</surname><given-names>T.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fecteau</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sparks</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Marijuana use and the risk of early ischemic stroke: the stroke prevention in young adults study</article-title><source>Stroke</source><volume>52</volume><issue>10</issue><year>2021</year><fpage>3184</fpage><lpage>3190</lpage><pub-id pub-id-type="pmid">34266309</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.120.032811</pub-id><pub-id pub-id-type="pmcid">PMC8478805</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sbref26"><person-group person-group-type="author"><name name-style="western"><surname>Falkstedt</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>V.</given-names></name><name name-style="western"><surname>Allebeck</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hemmingsson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Danielsson</surname><given-names>A.K.</given-names></name></person-group><article-title>Cannabis, tobacco, alcohol use, and the risk of early stroke: a population-based cohort study of 45&#8201;000 Swedish men</article-title><source>Stroke</source><volume>48</volume><issue>2</issue><year>2017</year><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">28028147</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.116.015565</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sbref27"><person-group person-group-type="author"><name name-style="western"><surname>Hemachandra</surname><given-names>D.</given-names></name><name name-style="western"><surname>McKetin</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cherbuin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Anstey</surname><given-names>K.J.</given-names></name></person-group><article-title>Heavy cannabis users at elevated risk of stroke: evidence from a general population survey</article-title><source>Aust. N. Z. J. Public Health</source><volume>40</volume><issue>3</issue><year>2016</year><fpage>226</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">26558539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1753-6405.12477</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sbref28"><person-group person-group-type="author"><name name-style="western"><surname>Karki</surname><given-names>N.</given-names></name><name name-style="western"><surname>Sapkota</surname><given-names>B.</given-names></name><name name-style="western"><surname>Magar</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Muhammad</surname><given-names>A.</given-names></name><name name-style="western"><surname>Paudel</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Chernek</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Relationship between marijuana use and hospitalization for acute coronary syndrome</article-title><source>Cureus</source><volume>14</volume><issue>3</issue><year>2022</year><object-id pub-id-type="publisher-id">e23317</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.23317</pub-id><pub-id pub-id-type="pmcid">PMC9014837</pub-id><pub-id pub-id-type="pmid">35464549</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sbref29"><person-group person-group-type="author"><name name-style="western"><surname>Ladha</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Mistry</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wijeysundera</surname><given-names>D.N.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>H.</given-names></name><name name-style="western"><surname>Verma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hare</surname><given-names>G.M.T.</given-names></name><etal/></person-group><article-title>Recent cannabis use and myocardial infarction in young adults: a cross-sectional study</article-title><source>CMAJ</source><volume>193</volume><issue>35</issue><year>2021</year><fpage>E1377</fpage><lpage>e84</lpage><pub-id pub-id-type="pmid">34493564</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1503/cmaj.202392</pub-id><pub-id pub-id-type="pmcid">PMC8443297</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sbref30"><person-group person-group-type="author"><name name-style="western"><surname>Lorenz</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mukerji</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Holman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Uno</surname><given-names>H.</given-names></name><name name-style="western"><surname>Gabuzda</surname><given-names>D.</given-names></name></person-group><article-title>Marijuana use impacts midlife cardiovascular events in HIV-infected men</article-title><source>Clin. Infect. Dis.: Off. Publ. Infect. Dis. Soc. Am.</source><volume>65</volume><issue>4</issue><year>2017</year><fpage>626</fpage><lpage>635</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cid/cix391</pub-id><pub-id pub-id-type="pmcid">PMC5850013</pub-id><pub-id pub-id-type="pmid">28449059</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sbref31"><person-group person-group-type="author"><name name-style="western"><surname>Malhotra</surname><given-names>K.</given-names></name><name name-style="western"><surname>Rumalla</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>M.K.</given-names></name></person-group><article-title>Association and clinical outcomes of marijuana in patients with intracerebral hemorrhage</article-title><source>J. Stroke Cereb. Dis.</source><volume>27</volume><issue>12</issue><year>2018</year><fpage>3479</fpage><lpage>3486</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jstrokecerebrovasdis.2018.08.011</pub-id><pub-id pub-id-type="pmid">30197168</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sbref32"><person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>K.T.</given-names></name><name name-style="western"><surname>Pedula</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Choi</surname><given-names>N.G.</given-names></name><name name-style="western"><surname>Tawara</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Simiola</surname><given-names>V.</given-names></name><name name-style="western"><surname>Satre</surname><given-names>D.D.</given-names></name><etal/></person-group><article-title>Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study</article-title><source>Drug Alcohol Depend.</source><volume>234</volume><year>2022</year><object-id pub-id-type="publisher-id">109387</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2022.109387</pub-id><pub-id pub-id-type="pmid">35279458</pub-id></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sbref33"><person-group person-group-type="author"><name name-style="western"><surname>Reis</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Auer</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bancks</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Goff</surname><given-names>D.C.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Lewis</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Pletcher</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: the coronary artery risk development in young adults (CARDIA) study</article-title><source>Am. J. Public Health</source><volume>107</volume><issue>4</issue><year>2017</year><fpage>601</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">28207342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2105/AJPH.2017.303654</pub-id><pub-id pub-id-type="pmcid">PMC5343712</pub-id></element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sbref34"><person-group person-group-type="author"><name name-style="western"><surname>San Luis</surname><given-names>C.V.</given-names></name><name name-style="western"><surname>O'Hana</surname><given-names>S.N.C.</given-names></name><name name-style="western"><surname>Shekhar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sugg</surname><given-names>R.</given-names></name><name name-style="western"><surname>Villareal</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Association between recent cannabinoid use and acute ischemic stroke</article-title><source>Neurol. Clin. Pr.</source><volume>10</volume><issue>4</issue><year>2020</year><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/CPJ.0000000000000888</pub-id><pub-id pub-id-type="pmcid">PMC7508332</pub-id><pub-id pub-id-type="pmid">32983613</pub-id></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sbref35"><person-group person-group-type="author"><name name-style="western"><surname>Sarmiento</surname><given-names>I.C.</given-names></name><name name-style="western"><surname>Giammarino</surname><given-names>A.</given-names></name><name name-style="western"><surname>Scheinerman</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Guirola</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hartman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Brinster</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Marijuana: an underappreciated risk factor for acute type a aortic dissection?</article-title><source>Heart Surg. Forum</source><volume>24</volume><issue>1</issue><year>2021</year><fpage>E137</fpage><lpage>E142</lpage><pub-id pub-id-type="pmid">33635252</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1532/hsf.3409</pub-id></element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sbref36"><person-group person-group-type="author"><name name-style="western"><surname>Stupinski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bible</surname><given-names>L.</given-names></name><name name-style="western"><surname>Asmar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chehab</surname><given-names>M.</given-names></name><name name-style="western"><surname>Douglas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ditillo</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Impact of marijuana on venous thromboembolic events: cannabinoids cause clots in trauma patients</article-title><source>J. Trauma Acute Care Surg.</source><volume>89</volume><issue>1</issue><year>2020</year><fpage>125</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">32209959</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/TA.0000000000002667</pub-id></element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sbref37"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>W.</given-names></name></person-group><article-title>Association of cannabis use with all-cause and cause-specific mortality among younger- and middle-aged U.S. adults</article-title><source>Am. J. Prev. Med</source><volume>59</volume><issue>6</issue><year>2020</year><fpage>873</fpage><lpage>879</lpage><pub-id pub-id-type="pmid">33220757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amepre.2020.07.010</pub-id></element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sbref38"><person-group person-group-type="author"><name name-style="western"><surname>Winhusen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Theobald</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kaelber</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>D.</given-names></name></person-group><article-title>The association between regular cannabis use, with and without tobacco co-use, and adverse cardiovascular outcomes: cannabis may have a greater impact in non-tobacco smokers</article-title><source>Am. J. Drug Alcohol Abus.</source><volume>46</volume><issue>4</issue><year>2020</year><fpage>454</fpage><lpage>461</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00952990.2019.1676433</pub-id><pub-id pub-id-type="pmcid">PMC7702298</pub-id><pub-id pub-id-type="pmid">31743053</pub-id></element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sbref39"><person-group person-group-type="author"><name name-style="western"><surname>Zongo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dyck</surname><given-names>J.R.B.</given-names></name><name name-style="western"><surname>El-Mourad</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hyshka</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hanlon</surname><given-names>J.G.</given-names></name><etal/></person-group><article-title>Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study</article-title><source>BMC Cardiovasc Disord.</source><volume>21</volume><issue>1</issue><year>2021</year><fpage>426</fpage><pub-id pub-id-type="pmid">34507536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12872-021-02229-6</pub-id><pub-id pub-id-type="pmcid">PMC8431905</pub-id></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sbref40"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Odom</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R.</given-names></name><name name-style="western"><surname>Loustalot</surname><given-names>F.</given-names></name><name name-style="western"><surname>Coleman King</surname><given-names>S.</given-names></name></person-group><article-title>Nonmedical marijuana use and cardiovascular events: a systematic review</article-title><source>Public Health Rep.</source><volume>137</volume><issue>1</issue><year>2022</year><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">33636088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0033354920988285</pub-id><pub-id pub-id-type="pmcid">PMC8721763</pub-id></element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sbref41"><person-group person-group-type="author"><name name-style="western"><surname>Desai</surname><given-names>R.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>U.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name><name name-style="western"><surname>Amin</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bhuva</surname><given-names>R.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>M.S.</given-names></name><etal/></person-group><article-title>Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States</article-title><source>Cureus</source><volume>9</volume><issue>11</issue><year>2017</year><fpage>e1816-NA</fpage><pub-id pub-id-type="pmid">29312837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.1816</pub-id><pub-id pub-id-type="pmcid">PMC5752226</pub-id></element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sbref42"><person-group person-group-type="author"><name name-style="western"><surname>Jouanjus</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lapeyre-Mestre</surname><given-names>M.</given-names></name><name name-style="western"><surname>Micallef</surname><given-names>J.</given-names></name></person-group><article-title>Cannabis use: signal of increasing risk of serious cardiovascular disorders</article-title><source>J. Am. Heart Assoc.</source><volume>3</volume><issue>2</issue><year>2014</year><object-id pub-id-type="publisher-id">e000638</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.113.000638</pub-id><pub-id pub-id-type="pmcid">PMC4187498</pub-id><pub-id pub-id-type="pmid">24760961</pub-id></element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sbref43"><person-group person-group-type="author"><name name-style="western"><surname>Mittleman</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Maclure</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sherwood</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>J.E.</given-names></name></person-group><article-title>Triggering myocardial infarction by marijuana</article-title><source>Circulation</source><volume>103</volume><issue>23</issue><year>2001</year><fpage>2805</fpage><lpage>2809</lpage><pub-id pub-id-type="pmid">11401936</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.cir.103.23.2805</pub-id></element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sbref44"><person-group person-group-type="author"><name name-style="western"><surname>Deusch</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kress</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Kraft</surname><given-names>B.</given-names></name><name name-style="western"><surname>Kozek-Langenecker</surname><given-names>S.A.</given-names></name></person-group><article-title>The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets</article-title><source>Anesth. Analg.</source><volume>99</volume><issue>4</issue><year>2004</year><fpage>1127</fpage><lpage>1130</lpage><pub-id pub-id-type="pmid">15385362</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/01.ANE.0000131505.03006.74</pub-id></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sbref45"><person-group person-group-type="author"><name name-style="western"><surname>Mendiz&#225;bal</surname><given-names>V.E.</given-names></name><name name-style="western"><surname>Adler-Graschinsky</surname><given-names>E.</given-names></name></person-group><article-title>Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions</article-title><source>Br. J. Pharm.</source><volume>151</volume><issue>4</issue><year>2007</year><fpage>427</fpage><lpage>440</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.bjp.0707261</pub-id><pub-id pub-id-type="pmcid">PMC2013961</pub-id><pub-id pub-id-type="pmid">17450170</pub-id></element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sbref46"><person-group person-group-type="author"><name name-style="western"><surname>Hirvonen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Goodwin</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Terry</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Zoghbi</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Morse</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers</article-title><source>Mol. Psychiatry</source><volume>17</volume><issue>6</issue><year>2012</year><fpage>642</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">21747398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/mp.2011.82</pub-id><pub-id pub-id-type="pmcid">PMC3223558</pub-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sbref47"><person-group person-group-type="author"><name name-style="western"><surname>Vin-Raviv</surname><given-names>N.</given-names></name><name name-style="western"><surname>Akinyemiju</surname><given-names>T.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Sakhuja</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hayward</surname><given-names>R.</given-names></name></person-group><article-title>Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database</article-title><source>Cancer Med</source><volume>6</volume><issue>1</issue><year>2017</year><fpage>320</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">27891823</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cam4.968</pub-id><pub-id pub-id-type="pmcid">PMC5269570</pub-id></element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sbref48"><person-group person-group-type="author"><name name-style="western"><surname>Moon</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>W.</given-names></name><name name-style="western"><surname>Mullen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ponce</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>McGwin</surname><given-names>G.</given-names></name><name name-style="western"><surname>Shah</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Marijuana use and mortality following orthopedic surgical procedures</article-title><source>Subst. Abus</source><volume>40</volume><issue>3</issue><year>2019</year><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="pmid">29558287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/08897077.2018.1449054</pub-id></element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sbref49"><person-group person-group-type="author"><name name-style="western"><surname>Rumalla</surname><given-names>K.</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>M.K.</given-names></name></person-group><article-title>Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States</article-title><source>J. Neurol. Sci.</source><volume>364</volume><year>2016</year><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">26874461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jns.2016.01.066</pub-id></element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sbref50"><person-group person-group-type="author"><name name-style="western"><surname>Rumalla</surname><given-names>K.</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>A.Y.</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>M.K.</given-names></name></person-group><article-title>Association of recreational marijuana use with aneurysmal subarachnoid hemorrhage</article-title><source>J. Stroke Cereb. Dis.</source><volume>25</volume><issue>2</issue><year>2016</year><fpage>452</fpage><lpage>460</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jstrokecerebrovasdis.2015.10.019</pub-id><pub-id pub-id-type="pmid">26708529</pub-id></element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sbref51"><person-group person-group-type="author"><name name-style="western"><surname>Westover</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>McBride</surname><given-names>S.</given-names></name><name name-style="western"><surname>Haley</surname><given-names>R.W.</given-names></name></person-group><article-title>Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients</article-title><source>Arch. Gen. Psychiatry</source><volume>64</volume><issue>4</issue><year>2007</year><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">17404126</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpsyc.64.4.495</pub-id></element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sbref52"><person-group person-group-type="author"><name name-style="western"><surname>Kariyanna</surname><given-names>P.T.</given-names></name><name name-style="western"><surname>Wengrofsky</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jayarangaiah</surname><given-names>A.</given-names></name><name name-style="western"><surname>Haseeb</surname><given-names>S.</given-names></name><name name-style="western"><surname>Salciccioli</surname><given-names>L.</given-names></name><name name-style="western"><surname>Hegde</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Marijuana and cardiac arrhythmias: a scoping study</article-title><source>Int J. Clin. Res.Trials</source><volume>4</volume><issue>1</issue><year>2019</year></element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sbref53"><person-group person-group-type="author"><name name-style="western"><surname>Charbonney</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sztajzel</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Poletti</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Rutschmann</surname><given-names>O.</given-names></name></person-group><article-title>Paroxysmal atrial fibrillation after recreational marijuana smoking: another "holiday heart"?</article-title><source>Swiss Med Wkly</source><volume>135</volume><issue>27&#8211;28</issue><year>2005</year><fpage>412</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">16220412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4414/smw.2005.11014</pub-id></element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sbref54"><person-group person-group-type="author"><name name-style="western"><surname>Korantzopoulos</surname><given-names>P.</given-names></name></person-group><article-title>Marijuana smoking is associated with atrial fibrillation</article-title><source>Am. J. Cardiol.</source><volume>113</volume><issue>6</issue><year>2014</year><fpage>1085</fpage><lpage>1086</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.amjcard.2014.01.001</pub-id><pub-id pub-id-type="pmid">24581720</pub-id></element-citation></ref></ref-list><sec id="sec0100" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary material</title><p id="p0190"><supplementary-material content-type="local-data" id="ec0005" position="float" orientation="portrait"><caption><p>Supplementary material</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc1.docx" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0195"><supplementary-material content-type="local-data" id="ec0010" position="float" orientation="portrait"><caption><p>Supplementary material</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc2.docx" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0200"><supplementary-material content-type="local-data" id="ec0015" position="float" orientation="portrait"><caption><p>Supplementary material</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc3.docx" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0205"><supplementary-material content-type="local-data" id="ec0020" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 1</bold> Forest plot of analysis regarding ischemic stroke and TIA. Individual trials and pooled analyses revealed an insignificant increase risk of ischemic stroke and TIA in the cannabis use group. CI =&#8201;confidence interval; OR =&#8201;odds ratio; TIA =&#8201;transient ischemic attack.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc4.jpg" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0210"><supplementary-material content-type="local-data" id="ec0025" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 2</bold> Forest plot of analysis regarding hemorrhagic stroke. Individual trials and pooled analyses revealed an insignificant increase risk of ischemic stroke and TIA in the cannabis use group. CI =&#8201;confidence interval; OR =&#8201;odds ratio.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc5.jpg" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0215"><supplementary-material content-type="local-data" id="ec0030" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 3</bold> Forest plot of subgroup analysis of composite adverse CV event. CI =&#8201;confidence interval; CV =&#8201;cardiovascular; OR =&#8201;odds ratio.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc6.jpg" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0220"><supplementary-material content-type="local-data" id="ec0035" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 4</bold> Funnel plot of studies regarding myocardial infarction.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc7.jpg" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0225"><supplementary-material content-type="local-data" id="ec0040" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 5</bold> Funnel plot of studies regarding stroke.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc8.jpg" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0230"><supplementary-material content-type="local-data" id="ec0045" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 6</bold> Funnel plot of studies regarding ischemic stroke and TIA.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc9.jpg" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0235"><supplementary-material content-type="local-data" id="ec0050" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 7</bold> Funnel plot of studies regarding hemorrhagic stroke.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc10.jpg" position="float" orientation="portrait"/></supplementary-material>.</p><p id="p0240"><supplementary-material content-type="local-data" id="ec0055" position="float" orientation="portrait"><caption><p><bold>Supplementary figure 8</bold> Funnel plot of studies regarding composite adverse cardiovascular events.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mmc11.jpg" position="float" orientation="portrait"/></supplementary-material>.</p></sec><sec sec-type="data-availability" id="da0005"><title>Data Availability</title><p id="p0030">Data will be made available on request.</p></sec><ack id="ack0005"><title>Acknowledgments</title><p id="p0175">We would like to thank all faculties and staff of the division of cardiovascular medicine, cardiac center, King Chulalongkorn memorial hospital, especially Asst.Prof. Smonporn Boonyaratavej and Assoc.Prof. Sarinya Puwanant for being our inspiration to initiate and complete this exceptional work.</p><p id="p0180">The authors acknowledge the support for article processing from Cardiac Center, King Chulalongkorn Memorial Hospital.</p></ack><fn-group><fn id="sec0095" fn-type="supplementary-material"><label>Appendix A</label><p id="p0185">Supplementary data associated with this article can be found in the online version at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.toxrep.2023.04.011" id="ir0005">doi:10.1016/j.toxrep.2023.04.011</ext-link>.</p></fn></fn-group></back></article></pmc-articleset>